Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Maged Argalious, MD, MSc, MBA, MEd is a Staff Physician in the Department of General Anesthesia at the Cleveland Clinic. He is also Professor of Anesthesiology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr Argalious serves as Program Director of the Anesthesiology Residency Program and is the Director of the Center for Anesthesiology Education within the Anesthesia Institute. Certified by the American Board of Anesthesiology and in Perioperative Transesophageal Echocardiography, Dr. Argalious' special interests include anesthesia for vascular surgery and anesthesia for liver transplantation and perioperative medicine.
anesthesia for liver transplantation, anesthesia for patients with difficult airways, anesthesia for vascular surgery, anesthesia recovery, cardiothoracic anesthesia, clinical pharmacology, clinical research on perioperative inflammation, continuous quality improvement, difficult airway management, education, fiberoptic intubation, general anesthesia, hepatic transplantation anesthesia, intraoperative TEE, liver transplantation, malignant hyperthermia, outcomes research, perioperative management, perioperative medicine, physician teaching and training, research and teaching clinical anesthesia, residency training, resident education, resident teaching, solid organ transplantation, vascular anesthesia
Awards & Honors
Anesthesiologist of theYear Award, Cleveland Clinic, 2004
Certification in Advanced Perioperative Transesophageal Echocardiography
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/6/2016, Dr. Argalious has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.